Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-08-20

Clinical Trial Update: Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure

View source ↗

Summary

A completed clinical trial investigating whether measuring G protein-coupled receptor kinase-2 (GRK2) in blood can aid diagnosis and treatment of heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Heart Failure | Status: COMPLETED